Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Terazosin

Cheng H. Yang  1 , Avais Raja  2
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Terazosin

Cheng H. Yang et al.
Free Books & Documents

Excerpt

Terazosin is a medication used in the management and treatment of benign prostatic hyperplasia and essential hypertension. Terazosin is a long-acting, selective alpha-1 adrenergic receptor antagonist. This activity reviews the indications, action, and contraindications for Terazosin as a valuable agent in managing benign prostatic hyperplasia, essential hypertension, and nephrolithiasis.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Cheng Yang declares no relevant financial relationships with ineligible companies.

Disclosure: Avais Raja declares no relevant financial relationships with ineligible companies.

References

    1. Itskovitz HD. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings. Clin Ther. 1994 May-Jun;16(3):490-504. - PubMed
    1. Kaplan SA. alpha-Blocker Therapy: Current Update. Rev Urol. 2005;7 Suppl 8(Suppl 8):S34-42. - PMC - PubMed
    1. Ghaleiha A, Shahidi KM, Afzali S, Matinnia N. Effect of terazosin on sweating in patients with major depressive disorder receiving sertraline: a randomized controlled trial. Int J Psychiatry Clin Pract. 2013 Feb;17(1):44-7. - PubMed
    1. Sridharan K, Sivaramakrishnan G. Efficacy and safety of alpha blockers in medical expulsive therapy for ureteral stones: a mixed treatment network meta-analysis and trial sequential analysis of randomized controlled clinical trials. Expert Rev Clin Pharmacol. 2018 Mar;11(3):291-307. - PubMed
    1. Preminger GM, Tiselius HG, Assimos DG, Alken P, Buck C, Gallucci M, Knoll T, Lingeman JE, Nakada SY, Pearle MS, Sarica K, Türk C, Wolf JS, EAU/AUA Nephrolithiasis Guideline Panel 2007 guideline for the management of ureteral calculi. J Urol. 2007 Dec;178(6):2418-34. - PubMed

Publication types

LinkOut - more resources